927T > C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis

Pediatric Allergy and Immunology

Volumn 17, Issue 5, 2006, Pages 323-328

  Arriba Mendez, Sonia ^a   Sanz, Catalina ^b   Isidoro Garcia, Maria ^c,d   Davild, Ignacio ^b   Laffond, Elena ^b   Horeno, Esther ^b   Avila, Carmelo ^c   Lorente, Felix ^b  

^a HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Asthma; Atopic dermatitis; CYSLTR1; Genes; Pediatrics; Polymorphisms

Indexed keywords

CYSTEINYLLEUKOTRIENE TYPE 1 RECEPTOR; LEUKOTRIENE RECEPTOR; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG;

ALLELISM; ANAMNESIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CONTROLLED STUDY; CYSLTR1 GENE; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRICK TEST; PRIORITY JOURNAL; RECEPTOR GENE; RNA TRANSLATION; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

ADOLESCENT; ADULT; ALLELES; ASTHMA; CHILD; DERMATITIS, ATOPIC; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LEUKOTRIENE; TH2 CELLS;

EID: 33745601648     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2006.00416.x     Document Type: Article

References (30)

1. ASHER MI, ANDERSON HR, STEWART AW, et al. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998: 12: 315-35.
2. WILLIAMS H, ROBERTSON C, STEWART A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999: 103: 125-38.
3. LUOMA R, KOIVIKKO A, VIANDER M. Development of asthma, allergic rhinitis and atopic dermatitis by the age of five years. A prospective study of 543 newborns. Allergy 1983: 38: 339-46.
4. SPORIK R, HOLGATE ST, COGSWELL JJ. Natural history of asthma in childhood - a birth cohort study. Arch Dis Child 1991: 66: 1050-53.
5. HOWARD TD, MEYERS DA, BLEECKER ER. Mapping susceptibility genes for allergic diseases. Chest 2003: 123 (Suppl. 3): 363S-8S.
6. HOJAN S, EPPLEN JT. The genetics of atopic dermatitis: recent findings and future options. J Mol Med 2005: 83: 682-92.
7. LEUNG DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000: 105: 860-76.
8. RUZICKA T, RING J. Enhanced releasability of prostaglandin E2 and leukotrienes B4 and C4 from leukocytes of patients with atopic eczema. Acta Derm Venereol 1987: 67: 469-75.
9. LYNCH KR, O'NEILL GP, LIU Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999: 399: 789-93.
10. CHOI JH, PARK HS, OH HB, et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004: 114: 337-44.
11. ISIDORO-GARCIA M, DAVILA I, LAFFOND E, MORENO E, LORENTE F, GONZALEZ-SARMIENTO R. Interleukin-4 (IL4) and Interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study. Clin Mol Allergy 2005: 3: 15.
12. SHI YY, HE L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005: 15: 97-8.
13. HOLGATE ST, PETERS-GOLDEN M, PANETTIERI RA, HENDERSON WR Jr. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003: 111 (Suppl. 1): S18-S34.
14. OYMAR K, AKSNES L. Increased levels of urinary leukotriene E4 in children with severe atopic eczema/dermatitis syndrome. Allergy 2005: 60: 86-9.
15. KNORR B, FRANCHI LM, BISGAARD H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001: 108: E48.
16. STRAUB DA, MOELLER A, MINOCCHIERI S, et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur Respir J 2005: 25: 289-94.
17. CAPELLA GL, GRIGERIO E, ALTOMARE G. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Eur J Dermatol 2001: 11: 209-13.
18. CARUCCI JA, WASHENIK K, WEINSTEIN A, SHUPACK J, COHEN DE. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998: 134: 785-6.
19. WOODMANSEE DP, SIMON RA. A pilot study examining the role of zileuton in atopic dermatitis. Ann Allergy Asthma Immunol 1999: 83: 548-52.
20. YANASE DJ, DAVID-BAJAR K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol 2001: 44: 89-93.
21. VEIEN NK, BUSCH-SORENSEN M, STAUSBOL-GRON B. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2005: 53: 147-9.
22. MALMSTROM K, RODRIGUEZ-GOMEZ G, GUERRA J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999: 130: 487-95.
23. SAMPSON AP, SIDDIQUI S, BUCHANAN D, et al. Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 2000: 55 (Suppl. 2): S28-31.
24. BJORNSON CL, MITCHELL I. Gender differences in asthma in childhood and adolescence. J Gend Specif Med 2000: 3: 57-61.
25. BRADLEY M, SODERHALL C, WAHLGREN CF, LUTHMAN H, NORDENSKJOLD M, KOCKUM I. The Wiskott-Aldrich syndrome gene as a candidate gene for atopic dermatitis. Acta Derm Venereol 2001: 81: 340-2.
26. VIELUF D, KORTING HC, BELOHRADSKY BH. Eczematous skin lesions in X-linked immunodeficiency with hyper-IgM. Curr Probl Dermatol 1989: 18: 60-5.
27. FUKAI H, OGASAWARA Y, MIGITA O, et al. Association between a polymorphism in cysteinyl leukotriene receptor 2 on chromosome 13q14 and atopic asthma. Pharmacogenetics 2004: 14: 683-90.
28. SANAK M, PIERZCHALSKA M, BAZAN-SOCHA S, SZCZEKLIK A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000: 23: 290-6.
29. ISIDORO-GARCIA M, DAVILA I, MORENO E, LORENTE F, GONZALEZ-SARMIENTO R. Analysis of the leukotriene C4 synthase A-444C promoter polymorphism in a Spanish population. J Allergy Clin Immunol 2005: 115: 206-7.
30. THOMPSON MD, STORM VAN'S GK, GALCZENSKI H, et al. A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. Pharmacogenetics 2003: 13: 641-9.